These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 4840150)
1. [Tests and controls of therapeutic materials and agents]. Dollery CT Reumatologia; 1974; 12(2):28-38. PubMed ID: 4840150 [No Abstract] [Full Text] [Related]
2. [Tests and controls of therapeutic materials and agents]. Dollery CT An Esp Odontoestomatol; 1974; 33(5):411-20. PubMed ID: 4530643 [No Abstract] [Full Text] [Related]
3. From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials. Heemskerk J; Tobin AJ; Ravina B Nat Neurosci; 2002 Nov; 5 Suppl():1027-9. PubMed ID: 12403977 [No Abstract] [Full Text] [Related]
4. Towards meaningful laboratory tests for evaluation of pharmaceutical aerosols. Clark AR; Gonda I; Newhouse MT J Aerosol Med; 1998; 11 Suppl 1():S1-7. PubMed ID: 10180719 [No Abstract] [Full Text] [Related]
5. Cellular systems for toxicity testing. Ann N Y Acad Sci; 1983; 407():1-484. PubMed ID: 6576676 [No Abstract] [Full Text] [Related]
6. Cancer risks of medical treatment. Part I: Monitoring for drug safety and efficacy. Schottenfeld D Clin Bull; 1980; 10(4):150-7. PubMed ID: 7011593 [No Abstract] [Full Text] [Related]
8. The discovery and development of new antileukemic drugs. Grever M; Malspeis L Hematol Oncol Clin North Am; 1993 Feb; 7(1):233-54. PubMed ID: 8449860 [TBL] [Abstract][Full Text] [Related]
10. [Salvin, an antibiotic from Salvia officinalis]. Aĭzenman BE; Derbentseva NA; Zelepukha SI; Negrash AK; Volosovets PS Mikrobiol Zh (1978); 1982; 44(3):69-72. PubMed ID: 7121324 [No Abstract] [Full Text] [Related]
11. Immunosuppressants of tomorrow. Wagner T Nephrol News Issues; 1997 Aug; 11(8):38-9. PubMed ID: 9335782 [No Abstract] [Full Text] [Related]
12. [Simple skin tests in the initial evaluation of the tolerance of a topical medication or cosmetic]. Assier-Bonnet H; Revuz J Ann Dermatol Venereol; 1998 Dec; 125(12):916-8. PubMed ID: 9922869 [No Abstract] [Full Text] [Related]
13. [Conception and birth of a drug]. Prost JF Rev Infirm; 1981 Dec; 31(19):57-61. PubMed ID: 6916407 [No Abstract] [Full Text] [Related]
14. [Preclinical prognosis of pyracetam and picamilon safety based on acute toxicity data]. Bugaeva LI; Spasov AA; Verovskiĭ VE; Iezhitsa IN Eksp Klin Farmakol; 2003; 66(4):43-6. PubMed ID: 14558352 [TBL] [Abstract][Full Text] [Related]
16. [The drug therapy of osteoarthrosis: its status and outlook]. Mitrovic D Ter Arkh; 1993; 65(5):69-72. PubMed ID: 8036602 [No Abstract] [Full Text] [Related]
17. [Importance of "screening tests" for the biological trial of materials]. Schmalz G Dtsch Zahnarztl Z; 1982 Oct; 37(10):829-32. PubMed ID: 6958448 [No Abstract] [Full Text] [Related]
18. How bad the drug lag? Clark M; Hager M; Gosnell M Newsweek; 1978 Oct; 92(15):119, 121. PubMed ID: 10297213 [No Abstract] [Full Text] [Related]
19. [Basic rules and problems of phase study of new anticancer agents]. Saito T Gan To Kagaku Ryoho; 1984 Mar; 11(3):377-82. PubMed ID: 6703716 [TBL] [Abstract][Full Text] [Related]